367 related articles for article (PubMed ID: 19916848)
1. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.
Ondo WG; Tintner R; Voung KD; Lai D; Ringholz G
Mov Disord; 2005 Aug; 20(8):958-63. PubMed ID: 15800937
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
7. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
8. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.
McManus DQ; Arvanitis LA; Kowalcyk BB
J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine for primary insomnia: a double blind, randomized controlled trial.
Tassniyom K; Paholpak S; Tassniyom S; Kiewyoo J
J Med Assoc Thai; 2010 Jun; 93(6):729-34. PubMed ID: 20572379
[TBL] [Abstract][Full Text] [Related]
14. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
Comella CL; Tanner CM; Ristanovic RK
Ann Neurol; 1993 Nov; 34(5):710-4. PubMed ID: 8239565
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in schizophrenia: onset of action within the first week of treatment.
Small JG; Kolar MC; Kellams JJ
Curr Med Res Opin; 2004 Jul; 20(7):1017-23. PubMed ID: 15265246
[TBL] [Abstract][Full Text] [Related]
18. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
Merims D; Balas M; Peretz C; Shabtai H; Giladi N
Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
[TBL] [Abstract][Full Text] [Related]
20. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
